Neurology 2014-04-08

Clinical reasoning: A 68-year-old man with a first presentation of status epilepticus.

Logan Schneider, John C Probasco, Scott D Newsome

Index: Neurology 82(14) , e116-21, (2014)

Full Text: HTML

Abstract

A 64-year-old man with transfusion-dependent myelodysplastic syndrome (MDS), hypertension, chronic obstructive pulmonary disease, hypothyroidism, blindness from treated syphilitic chorioretinitis, and no prior seizure history presented in generalized status epilepticus. His daily home medication regimen included prednisone 20 mg (chronic therapy for MDS), diltiazem 120 mg, digoxin 250 μg, tiotropium 80 μg, and levothyroxine 112 μg. On admission he was febrile to 39.9 °C and in atrial fibrillation with rapid ventricular rate. Initial hematologic profile showed 11,910 leukocytes/mm(3) (12% immature forms, 46% neutrophils, 32% lymphocytes), hematocrit of 30.8%, and platelet count of 215,000/mm(3), with an otherwise normal serum chemistry.

Related Compounds

  • digoxin
  • diltiazem hydrochl...

Related Articles:

Rapid detection of convallatoxin using five digoxin immunoassays.

2014-08-01

[Clin. Toxicol. (Phila.) 52(7) , 659-63, (2014)]

Effects of intestinal microbiota on the bioavailability of geniposide in rats.

2014-10-08

[J. Agric. Food Chem. 62(40) , 9632-6, (2014)]

Mechanism of an unusual, but clinically significant, digoxin-bupropion drug interaction.

2014-07-01

[Biopharm. Drug Dispos. 35(5) , 253-63, (2014)]

Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.

2014-07-01

[Antimicrob. Agents Chemother. 58(7) , 4064-74, (2014)]

Study on the pharmacokinetics profiles of polyphyllin I and its bioavailability enhancement through co-administration with P-glycoprotein inhibitors by LC-MS/MS method.

2015-03-25

[J. Pharm. Biomed. Anal. 107 , 119-24, (2015)]

More Articles...